4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-19-054530
Director bought 1,052,631 shares at $19.00 ($19,999,989)
- Director acquired 1,015,230 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Edwards Jonathan S. Director | 2019-10-29 | Conversion | +991,672 | $15.20 | $15,073,414 | 991,672 | I |
| Edwards Jonathan S. Director | 2019-10-29 | Conversion | +23,558 | $15.20 | $358,082 | 23,558 | I |
| Edwards Jonathan S. Director | 2019-10-29 | Purchase | +1,028,205 | $19.00 | $19,535,895 | 2,019,877 | I |
| Edwards Jonathan S. Director | 2019-10-29 | Purchase | +24,426 | $19.00 | $464,094 | 47,984 | I |
| Derivatives | |||||||
| Edwards Jonathan S. Director | 2019-10-29 | Conversion · Convertible Promissory Notes | −0 | 0 | I | ||
| Edwards Jonathan S. Director | 2019-10-29 | Conversion · Convertible Promissory Notes | −0 | 0 | I | ||
| Open-market purchases · 1,052,631 sh · avg $19.00 · $19,999,989 | |||||||
Loading xslF345X03/doc4.xml…